A Study for a Topical Medication Versus Placebo in Patients With Hand Dermatitis

Summary

This is a double-blind, pilot study with 20 subjects to determine the tolerability and efficacy of topical AFX 5931 in the treatment of mild to moderate hand dermatitis. Subjects are screened up to 30 days before the baseline visit. Subjects who meet the eligibility criteria may qualify for the study. Subjects will be randomized in a 3:1 ratio to receive either the active or vehicle medication. 15 subjects will receive the active, therapeutic product and 5 subjects will receive the inactive, vehicle product.

Timeline

Start

2018-09-18

Primary completion

2019-04-04

Completion

2019-04-04

Drugs

Indications